Renato Corporation Expands Corporate and Investor Relations Division

MIAMI, FL--(Marketwire - January 08, 2010) -

Renato Corporation (FRANKFURT: 4OZ) has appointed Mr. Paul Gordon and Mr. Edward Warner to assist Investor Relations Coordinator, Dave Reynolds, with the company’s growing corporate and investor related inquiries. Historically, Renato receives an increase in daily calls and emails early in the New Year regarding a wide range of queries. The additional staffing will allow for a much quicker and efficient response to these inquiries.

“It is essential that we have the appropriate staff available temporarily to respond to our shareholders and maintain an open line of communication,” stated Renato director, Arunas Morkunas.

Renato Corporation will continue to provide company updates via press release and on the company website at www.renatocorp.com

www.renatocorp.com

www.renatocorp.de

About Renato Corporation

Renato Corporation has decisively positioned itself to provide advanced diagnostic care via private clinics and health and wellness centers here in North America, and internationally. In addition the company is broadening its business base building generic pharmaceutical facilities in developing countries.

Our professionally staffed clinics will be equipped with the latest non-invasive diagnostic devices available to date. Renato Corporation will ensure that non-invasive diagnostic technologies such as Thermography and Electronic Beam Tomography (EBT) body scanning will be accessible to the general public.

At Renato Corporation, it is our pledge to continually seek out the latest innovative advanced medical diagnostic technologies available to continually provide the very best affordable private health care to our clients.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.